Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Compugen Ltd. Ordinary Shares
Compugen Ltd is a therapeutic discovery company. The Company's pipeline consists of early-stage immuno-oncology programs aimed at harnessing the immune system to fight cancer.
IPO Date: August 11, 2000
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $133.76M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.13 | 2.91%
Avg Daily Range (30 D): $0.02 | 1.68%
Avg Daily Range (90 D): $0.04 | 2.75%
Institutional Daily Volume
Avg Daily Volume: .3M
Avg Daily Volume (30 D): .19M
Avg Daily Volume (90 D): .2M
Trade Size
Avg Trade Size (Sh.): 175
Avg Trade Size (Sh.) (30 D): 225
Avg Trade Size (Sh.) (90 D): 214
Institutional Trades
Total Inst.Trades: 305
Avg Inst. Trade: $1.44M
Avg Inst. Trade (30 D): $.63M
Avg Inst. Trade (90 D): $.63M
Avg Inst. Trade Volume: .2M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.64M
Avg Closing Trade (30 D): $.63M
Avg Closing Trade (90 D): $.63M
Avg Closing Volume: 163.83K
   
News
Jul 2, 2024 @ 1:22 PM
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Brea...
Source: Zacks Equity Research
Jul 1, 2024 @ 2:31 PM
FDA Rejects Rocket's (RCKT) Gene Therapy BLA for R...
Source: Zacks Equity Research
Jul 1, 2024 @ 12:44 PM
Apellis (APLS) Falls on Second Negative CHMP Opini...
Source: Zacks Equity Research
Jul 1, 2024 @ 12:00 PM
PTC Therapeutics (PTCT) Down on Negative CHMP Opin...
Source: Zacks Equity Research
Jun 28, 2024 @ 1:18 PM
Cogent (COGT) Up on SUMMIT Study Update Post Posit...
Source: Zacks Equity Research